When to discontinue treatment of prolactinoma?
- 1 June 2006
- journal article
- Published by Springer Science and Business Media LLC in Nature Clinical Practice Endocrinology & Metabolism
- Vol. 2 (6), 298-299
- https://doi.org/10.1038/ncpendmet0162
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- The prevalence of pituitary adenomasCancer, 2004
- Withdrawal of Long-Term Cabergoline Therapy for Tumoral and Nontumoral HyperprolactinemiaThe New England Journal of Medicine, 2003
- Dopamine resistance of prolactinomas.Pituitary, 2003
- The effect of the menopause on prolactin levels in patients with hyperprolactinaemiaClinical Endocrinology, 2001
- Rapid re-expansion of a macroprolactinoma after early discontinuation of bromocriptine.Pituitary, 2000
- Cerebrospinril fluid rhinorrhea during treatment with bromocriptine for prolactinomaNeurology, 1985
- Necrotic Changes in Prolactinomas after Long Term Administration of Bromocriptine*Journal of Clinical Endocrinology & Metabolism, 1984
- EFFECT OF DOPAMINE AGONIST WITHDRAWAL AFTER LONG-TERM THERAPY IN PROLACTINOMAS: Studies with High-definition Computerised TomographyThe Lancet, 1984